Meeting the Clinical Needs of Patients
Nubratori RX currently has 12 products on the market.
These products are sold under the FDA Structured Product Listing,
Market Category, C181659: Outsourcing Facility Compounded Human Drug Product
(Exempt From Approval Requirements). Click image to enlarge.
 |  |  |  |  |
|---|---|---|---|---|
 |
Dexonto™ 0.4%, is a topical formulation of dexamethasone for iontophoresis.
Diclofono™ 1.6%, is a topical formulation of diclofenac to be used with or without ultrasound.
Frotek™ 10%, is a topical formulation of ketoprofen.
Lidocidex™ is an injectable sterile formulation consisting of lidocaine and dexamethasone.
Lidomar™ is an injectable sterile formulation consisting of lidocaine and bupivicane.
Neuraptine™ 10%, is a topical formulation of gabapentin.
Nubratori RX currently has ten additional products in the pipeline designed for non-opiate pain control for orthopedics, neurologists, and others in the pain management health care sector.
For more information on any of these formulations, please contact us and also peruse the section on white papers and articles, found here.
Nubratori RX products are batch tested, validated, and put through the required stability and potency testing prior to being released to the market.
Let us know how we can help you.
